CD8A and infection: In our earlier studies, we observed that genetic vaccination with a heterologous prime-boost regimen employing plasmid DNA and recombinant adenovirus elicited strong, long lasting CD8+ T cell-mediated protective immunity against experimental infection in a mouse strain highly susceptible to T. cruzi infection [37], [38].